Related Experiment Video
Updated: Jun 27, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
Published on: April 29, 2007
Key Opinion Leaders--SMi's inaugural conference understanding physician-pharmaceutical industry relationships
1Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK. vicki.mason@thomsonreuters.com
No abstract available in PubMed .
More Related Videos
06:05The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
05:47Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Biopharmaceutics and Pharmacokinetics: Overview
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect